Shanghai Pharmaceuticals Holding Co Ltd Cash Flow Reinvestment Rate
Shanghai Pharmaceuticals Holding Co Ltd cash flow reinvestment rate. Shanghai Pharmaceuticals Holding Co Ltd (601607) has a Cash Flow Reinvestment Rate of 0.31x as of September 2025, reinvesting CN¥487.63 Million (capex CN¥487.63 Million ) from operating cash flow of CN¥1.56 Billion. Explore 601607 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Shanghai Pharmaceuticals Holding Co Ltd (1999–2025)
Cash flow reinvestment rate of Shanghai Pharmaceuticals Holding Co Ltd from 1999 to 2025. Historical reinvestment intensity for Shanghai Pharmaceuticals Holding Co Ltd across 27 annual periods. Explore Shanghai Pharmaceuticals Holding Co Ltd (601607) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Shanghai Pharmaceuticals Holding Co Ltd Cash Flow Reinvestment Rate by Year (1999–2025)
Shanghai Pharmaceuticals Holding Co Ltd cash flow reinvestment rate by year from 1999 to 2025. Year-by-year capital reinvestment analysis for Shanghai Pharmaceuticals Holding Co Ltd. For the full cash flow conversion analysis, see 601607 cash flow metrics.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.60x | CN¥3.72 Billion | CN¥6.15 Billion | CN¥2.33 Billion | ▼ -37.4% |
| 2024 | 0.97x | CN¥5.62 Billion | CN¥5.83 Billion | CN¥2.40 Billion | ▼ -7.6% |
| 2023 | 1.04x | CN¥5.46 Billion | CN¥5.23 Billion | CN¥2.97 Billion | ▼ -67.3% |
| 2022 | 3.20x | CN¥15.16 Billion | CN¥4.74 Billion | CN¥2.68 Billion | ▲ +284.6% |
| 2021 | 0.83x | CN¥4.21 Billion | CN¥5.06 Billion | CN¥4.12 Billion | ▲ +49.0% |
| 2020 | 0.56x | CN¥3.82 Billion | CN¥6.84 Billion | CN¥3.01 Billion | ▼ -36.3% |
| 2019 | 0.88x | CN¥5.28 Billion | CN¥6.02 Billion | CN¥2.75 Billion | ▲ +6.1% |
| 2018 | 0.83x | CN¥2.59 Billion | CN¥3.14 Billion | CN¥1.94 Billion | ▼ -2.0% |
| 2017 | 0.84x | CN¥2.23 Billion | CN¥2.65 Billion | CN¥2.01 Billion | ▼ -67.3% |
| 2016 | 2.57x | CN¥5.01 Billion | CN¥1.95 Billion | CN¥2.12 Billion | ▲ +78.6% |
| 2015 | 1.44x | CN¥1.94 Billion | CN¥1.35 Billion | CN¥1.72 Billion | ▲ +49.0% |
| 2014 | 0.97x | CN¥1.29 Billion | CN¥1.34 Billion | CN¥1.29 Billion | ▲ +4.0% |
| 2013 | 0.93x | CN¥905.06 Million | CN¥973.45 Million | CN¥905.06 Million | ▲ +50.9% |
| 2012 | 0.62x | CN¥708.91 Million | CN¥1.15 Billion | CN¥708.91 Million | ▲ +164.0% |
| 2011 | 0.23x | CN¥413.54 Million | CN¥1.77 Billion | CN¥413.54 Million | ▼ -28.5% |
| 2010 | 0.33x | CN¥550.30 Million | CN¥1.69 Billion | CN¥550.30 Million | ▲ +171.1% |
| 2009 | 0.12x | CN¥79.97 Million | CN¥664.13 Million | CN¥79.97 Million | ▼ -62.0% |
| 2008 | 0.32x | CN¥90.50 Million | CN¥285.68 Million | CN¥90.50 Million | ▼ -19.4% |
| 2007 | 0.39x | CN¥192.29 Million | CN¥488.94 Million | CN¥192.29 Million | ▲ +51.3% |
| 2006 | 0.26x | CN¥151.60 Million | CN¥583.11 Million | CN¥151.60 Million | ▼ -90.4% |
| 2005 | 2.71x | CN¥198.09 Million | CN¥73.00 Million | CN¥198.09 Million | ▼ -34.2% |
| 2004 | 4.13x | CN¥254.38 Million | CN¥61.66 Million | CN¥254.38 Million | ▼ -98.8% |
| 2003 | 350.18x | CN¥169.58 Million | CN¥484.27K | CN¥169.58 Million | ▲ +12537.3% |
| 2002 | 2.77x | CN¥279.44 Million | CN¥100.84 Million | CN¥279.44 Million | ▲ +25.9% |
| 2001 | 2.20x | CN¥144.71 Million | CN¥65.73 Million | CN¥144.71 Million | ▲ +128.2% |
| 2000 | 0.96x | CN¥141.09 Million | CN¥146.22 Million | CN¥141.09 Million | ▲ +202.8% |
| 1999 | 0.32x | CN¥52.48 Million | CN¥164.67 Million | CN¥52.48 Million | — |